Publications by authors named "Dan Turner"

Claim this Profile
W
Whole Food Diet Induces Remission in Children and Young Adults With Mild to Moderate Crohn's Disease and Is More Tolerable Than Exclusive Enteral Nutrition: A Randomized Controlled Trial.
Yonat Aharoni-Frutkoff, Luba Plotkin, Daniel Pollak, Jessica Livovsky, Gili Focht, Dan Turner

Gastroenterology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Experience with Upadacitinib for Pediatric Acute Severe Ulcerative Colitis: An International Multicenter Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN.
Anat Yerushalmy-Feler, Elizabeth A Spencer, Suzannah Bergstein, Katarina Mitrova, Ondrej Hradsky, Dan Turner

Inflamm Bowel Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolomics reveal distinct molecular pathways associated with future risk of Crohn's Disease.
Mingyue Xue, Sun-Ho Lee, Jingchen Shao, Haim Leibovitzh, Hien Q Huynh, Dan Turner

Gut Microbes· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical stages of Crohn's disease defined by faecal calprotectin in asymptomatic first-degree relatives: screening framework for prevention trials.
Dan Turner, Sarah Kenigsberg, Gili Focht, Williams Turpin, Oren Ledder

Gut· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profile predicts response to antitumor necrosis factor in children with Crohn's disease: A Porto group biobank study, and a systematic review.
Ohad Atia, Asaf Azulay, Gili Focht, Oren Ledder, Raffi Lev-Tzion, Dan Turner

J Pediatr Gastroenterol Nutr· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of prediction models for anti-tumor necrosis factor treatment response in pediatric Crohn's disease: a systematic review and prospective cohort study.
Omer Rotem-Tryfus, Ben Kang, Esther Orlanski-Meyer, Oren Ledder, Raffi Lev Tzion, Dan Turner

J Crohns Colitis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease activity classification based on routinely collected blood tests in a prospective paediatric inflammatory bowel disease inception cohort.
Rona Lujan, Oren Ledder, Dotan Yogev, Raffi Lev-Tzion, Esther Orlanski-Meyer, Dan Turner

J Pediatr Gastroenterol Nutr· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vedolizumab for extraintestinal manifestations in pediatric inflammatory bowel disease: Results from the VedoKids study.
Giulia D'Arcangelo, Dan Turner, Oren Ledder, Esther Orlanski-Meyer, Efrat Broide

J Pediatr Gastroenterol Nutr· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of mirikizumab in paediatric participants with moderately-to-severely active ulcerative colitis (SHINE-1): a multicentre, open-label, non-randomised phase 2 trial.
Jess L Kaplan, Athos Bousvaros, Dan Turner, Marla Dubinsky, Amy Larkin

Lancet Gastroenterol Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Age-related and Disease-related Complications and Mortality in Elderly-onset Inflammatory Bowel Disease: A Population-based Study.
Dana Ben Hur, Guy Issaschar, Ran Moshe, Boris Lebedenko, Rona Lujan, Dan Turner

Clin Gastroenterol Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Effectiveness of QingDai (Indigo naturalis) in Children With Mild-to-Moderate Ulcerative Colitis: A Short-Term 6-Week Open-Label Trial.
Dotan Yogev, Yael Weintraub, Oren Ledder, Manar Matar, Alex Krauthammer, Dan Turner

Inflamm Bowel Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of O-GlcNAcylation in cardiac myocytes triggers the integrated stress response, contributing to heart failure.
Kyriakos N Papanicolaou, Wenxi Zhang, Aidan J Dunphy, Justin C Zhong, Clara Y Cho, Dan R Turner

J Biol Chem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sigmoidoscopy is sufficient to assess endoscopic response to therapy in pediatric ulcerative colitis: A cohort study.
Shira Yuval Bar-Asher, Esther Orlanski-Meyer, Ibrahim Shamasnah, Dotan Yogev, Dan Turner

J Pediatr Gastroenterol Nutr· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of an Infliximab Biosimilar vs. Originator in Inflammatory Bowel Diseases: A Noninferiority Nationwide Study From the epi-IIRN.
Hadas Labrisch-Kaye, Rachel Buchuk, Yiska Weisband, Amir Ben-Tov, Galia Zacay, Dan Turner

J Clin Gastroenterol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of paediatric ulcerative colitis, part 2: Acute severe colitis-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organization.
Amit Assa, Marina Aloi, Stephanie Van Biervliet, Jiri Bronsky, Javier M di Carpi, Turner Dan

J Pediatr Gastroenterol Nutr· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fecal Microbial Community Profiling Allows Discrimination of Phenotype and Treatment Response in Pediatric Crohn's Disease and Ulcerative Colitis-An International Meta-Analysis.
Denise Aldrian, Adam Pollio, Christoph Mayerhofer, Kay Diederen, Jonathan P Jacobs, Dan Turner

Inflamm Bowel Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of pediatric inflammatory bowel diseases in limited-resource settings: A position paper from the Paediatric IBD Porto Group of ESPGHAN.
Almuthe Christine Hauer, Mutaz Sultan, Andy Darma, Eyad Altamimi, Daniela Elena Serban, Dan Turner

J Pediatr Gastroenterol Nutr· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of paediatric ulcerative colitis, part 1: Ambulatory care-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation.
Eytan Wine, Marina Aloi, Stephanie Van Biervliet, Jiri Bronsky, Javier Martín di Carpi, Dan Turner

J Pediatr Gastroenterol Nutr· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A switch to infliximab may be more effective than ustekinumab following adalimumab pharmacodynamic failure in paediatric patients with Crohn's disease.
Galit Driban, Manar Matar, Rafi Lev-Tzion, Oren Ledder, Maya Granot, Dan Turner

Dig Liver Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning for predicting Crohn's disease from routine blood tests years before diagnosis: results from the epi-IIRN cohort.
Raffi Lev-Tzion, Amir S Dolev, Shira Yuval Bar-Asher, Ran Balicer, Amir Ben-Tov, Dan Turner

J Crohns Colitis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter: Predictors of Complicated Disease Course in Children and Adults With Ulcerative Colitis-Authors' Reply.
Ohad Atia, Dan Turner

Inflamm Bowel Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention and interception trials in inflammatory bowel disease: an international taskforce assessment on clinical trial design.
Sailish Honap, Nelly Agrinier, Joana Torres, Kenneth Croitoru, Sun-Ho Lee, Dan Turner

Lancet Gastroenterol Hepatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global evolution of inflammatory bowel disease across epidemiologic stages.
Lindsay Hracs, Joseph W Windsor, Julia Gorospe, Michael Cummings, Stephanie Coward, Dan Turner

Nature· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective Study.
Shlomi Cohen, Elizabeth A Spencer, Michael T Dolinger, David L Suskind, Katarina Mitrova, Dan Turner

Aliment Pharmacol Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethnic Disparities in the Management of Inflammatory Bowel Disease in Israel and Impact on Outcomes.
Elad Boaz, Oren Ledder, Ariella Bar-Gil Shitrit, Amir Dagan, Michael R Freund, Dan Turner

Crohns Colitis 360· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis